Skip to main content
. 2020 Jun 18;11:539. doi: 10.3389/fphys.2020.00539

Figure 4.

Figure 4

JMJD1C represses AMPK activation in cardiomyocytes. (A,B) The AMPK signaling pathway is repressed in hypertrophic hearts in humans and mice. **p < 0.01 vs. control or saline. n = 4 in each group. (C) Jmjd1c knockdown activates AMPK signaling. NRCMs were infected with adenovirus expressing shJmjd1c or shCtrl for 24 h, followed by Ang II treatment for an additional 24 h. **p < 0.01 vs. Ad-shCtrl. n = 3 in each group. (D) JMJD1C overexpression represses AMPK activation. NRCMs were infected with adenovirus expressing Jmjd1c for 24 h, followed by Ang II treatment for an additional 24 h. **p < 0.01 vs. Ad-Ctrl. n = 3 in each group.